“Smart” Natural Killer Cells For Cancer Treatment, A Interview With Sonny Hsiao of Acepodia | Podcast

TrialSite Staff February 10, 2021
0 Comments

 

We discuss “Smart” Natural Killer Cells for Cancer Treatment, Sonny Hsiao of Acepodia. A clinical trial targeting HER2-expressing solid tumors with “smart” NK cells.

 

Sonny Hsiao is the founder and CEO of Acepodia. Founded in 2016 the company seeks to develop new therapies in immune-oncology and cell therapy medicine. Put another way Acepodia is a novel technology platform that serves to arm immune cells with antibodies to cure cancer.


Company Website
LinkedIn

PODCAST

Categories: Podcast
Tagged: , , , , , , ,
TrialSite Staff

Responses

Report Content

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Anything overly promotional selling products or services

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.